Panossian A, Ashiku S, Kirchhoff C H, Randolph M A, Yaremchuk M J
Division of Plastic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA 02114, USA.
Plast Reconstr Surg. 2001 Aug;108(2):392-402. doi: 10.1097/00006534-200108000-00018.
This study determined the effects of chondrocyte source, cell concentration, and growth period on cartilage production when isolated porcine cells are injected subcutaneously in a nude mouse model. Chondrocytes were isolated from both ear and articular cartilage and were suspended in Ham's F-12 medium at concentrations of 10, 20, 40, and 80 million cells per cubic centimeter. Using the nude mouse model, each concentration group was injected subcutaneously in 100-microl aliquots and was allowed to incubate for 6 weeks in vivo. In addition, cells suspended at a fixed concentration of 40 million cells per cubic centimeter were injected in 100-microl aliquots and were incubated for 1, 2, 3, 4, 5, 6, 9, and 12 weeks. Each concentration or time period studied contained a total of eight mice, with four samples harvested per mouse for a final sample size of 32 constructs. All neocartilage samples were analyzed by histologic characteristics, mass, glycosaminoglycan level, and DNA content. Control groups consisted of native porcine ear and articular cartilage. Specimen mass increased with increasing concentration and incubation time. Ear neocartilage was larger than articular neocartilage at each concentration and time period. At 40 million cells per cubic centimeter, both ear and articular chondrocytes produced optimal neocartilage, without limitations in growth. Specimen mass increased with incubation time up to 6 weeks in both ear and articular samples. No significant variations in glycosaminoglycan content were found in either articular or ear neocartilage, with respect to variable chondrocyte concentration or growth period. Although articular samples demonstrated no significant trends in DNA content over time, ear specimens showed decreasing values through 6 weeks, inversely proportional to increase in specimen mass. Although both articular and ear sources of chondrocytes have been used in past tissue-engineering studies with success, this study indicates that a suspension of ear chondrocytes injected into a subcutaneous location will produce biochemical and histologic data with greater similarity to those of native cartilage. The authors believe that this phenomenon is attributable to the local environment in which isolated chondrocytes from different sources are introduced. The subcutaneous environment of native ear cartilage accommodates subcutaneously injected ear chondrocyte transplants better than articular transplants. Native structural and biochemical cues within the local environment are believed to guide the proliferation of the differentiated chondrocytes.
本研究确定了在裸鼠模型中皮下注射分离的猪细胞时,软骨细胞来源、细胞浓度和生长周期对软骨生成的影响。软骨细胞从耳软骨和关节软骨中分离出来,以每立方厘米1000万、2000万、4000万和8000万个细胞的浓度悬浮于哈姆F-12培养基中。使用裸鼠模型,每个浓度组以100微升的等分试样皮下注射,并在体内孵育6周。此外,以每立方厘米4000万个细胞的固定浓度悬浮的细胞以100微升的等分试样注射,并分别孵育1、2、3、4、5、6、9和12周。每个研究的浓度或时间段共有8只小鼠,每只小鼠采集4个样本,最终样本量为32个构建体。所有新软骨样本均通过组织学特征、质量、糖胺聚糖水平和DNA含量进行分析。对照组由天然猪耳软骨和关节软骨组成。样本质量随浓度和孵育时间的增加而增加。在每个浓度和时间段,耳新软骨均大于关节新软骨。在每立方厘米4000万个细胞时,耳软骨细胞和关节软骨细胞均产生最佳新软骨,且生长无限制。耳样本和关节样本的样本质量在孵育至6周时均随时间增加。关节新软骨或耳新软骨的糖胺聚糖含量在软骨细胞浓度或生长周期变化时均未发现显著差异。尽管关节样本的DNA含量随时间未显示出显著趋势,但耳样本在6周内显示出下降值,与样本质量增加成反比。尽管在过去的组织工程研究中,关节软骨细胞和耳软骨细胞来源均已成功使用,但本研究表明,皮下注射的耳软骨细胞悬液所产生的生化和组织学数据与天然软骨的数据更相似。作者认为,这种现象归因于引入不同来源的分离软骨细胞的局部环境。天然耳软骨的皮下环境比关节移植更能容纳皮下注射的耳软骨细胞移植。局部环境中的天然结构和生化线索被认为可指导分化软骨细胞的增殖。